What CONMED Corp does.

This Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (“Form 10-K”) contains certain forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and information relating to CONMED Corporation (“CONMED”, the “Company”, “we” or “us” — references to “CONMED”, the “Company”, “we” or “us” shall be deemed to include our direct and indirect subsidiaries unless the context otherwise requires) which are based on the beliefs of our management, as well as assumptions made by and information currently available to our management.

When used in this Form 10-K, the words “estimate”, “project”, “believe”, “anticipate”, “intend”, “expect” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, including those identified under the caption “Item 1A-Risk Factors” and elsewhere in this Form 10-K which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following:

Revenue and profit, by fiscal year.

More on CNMD.

• CONMED Corp summary
• CONMED Corp financial statements
• CONMED Corp key metrics
• CONMED Corp health scores and style box
• CONMED Corp earnings
• CONMED Corp dividends
• CONMED Corp valuation
• CONMED Corp ownership and insiders
• CONMED Corp peers

Figures from CONMED Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.